MRI changes in patients with newly diagnosed glioblastoma treated as part a Phase II trial with bavituximab, radiation, and temozolomide

Ly, I; Cardona, J; Beers, A; Chang, K; Brown, J; Reardon, D; Arrillaga-Romany, I; Dietrich, J; Forst, D; Lee, E; Jordan, J; Nayak, L; Wen, P; Batchelor, T; Curry, W; Kalpathy-Cramer, J; Gerstner, E

NEUROLOGY, 2019; 92 (15):